Skip to main content
Equibles
ATYR logo

ATYR · aTYR PHARMA INC · Webcasts, Transcripts & Audio

Track ATYR — free

Use ATYR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATYR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.29 0.00 (-1.31%)
Rebalance outlook locked
Market Cap
$31.18M
Shares
98.09M
Volume · Oct 6 856.73K Avg daily vol (3M) 3.24M

aTYR PHARMA INC Webcasts

Earnings calls, investor updates, investor days and conferences for aTYR PHARMA INC (ATYR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $8.06M $1.75M '20 Q1 20-05-12 ▲101.1% $189,000 −$6.45M '20 Q2 20-08-13 ▼19.6% $148,000 −$6.60M '20 Q3 20-11-12 · $2.05M −$4.93M '20 Q4 21-03-23 · $ −$13.24M '22 Q3 22-11-10 · $ −$14.76M '23 Q4 24-03-14 LATEST · $ −$14.97M '24 Q4 25-03-13
Conference
Investor event
2026-06-04
aTYR PHARMA INC (ATYR) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-20
aTYR PHARMA INC (ATYR) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-11
aTYR PHARMA INC (ATYR) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-11
aTYR PHARMA INC (ATYR) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2025-09-15
aTYR PHARMA INC (ATYR) September 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-03-13
aTYR PHARMA INC (ATYR) Q4 2024 Earnings Call Transcript
Confident tone Phase 3 EFZO-FIT study readout FDA alignment and statistical analysis plan Expanded Access Program (EAP)
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q4
2024-03-14
aTYR PHARMA INC (ATYR) Q4 2023 Earnings Call Transcript
Confident tone EFZO-FIT Phase 3 enrollment in pulmonary sarcoidosis Expanded Access Program (EAP) post-EFZO-FIT Preclinical pipeline and platform
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-03-09
aTYR PHARMA INC (ATYR) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
aTYR PHARMA INC (ATYR) Q3 2022 Earnings Call Transcript
Revenue
$
Diluted EPS
$-0.46
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
aTYR PHARMA INC (ATYR) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.44
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-13
aTYR PHARMA INC (ATYR) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.44
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-14
aTYR PHARMA INC (ATYR) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
aTYR PHARMA INC (ATYR) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.42
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-29
aTYR PHARMA INC (ATYR) Q2 2021 Earnings Call Transcript
Diluted EPS
$-0.64
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
aTYR PHARMA INC (ATYR) Q1 2021 Earnings Call Transcript
Diluted EPS
$-0.51
▼ 304% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-23
aTYR PHARMA INC (ATYR) Q4 2020 Earnings Call Transcript
Revenue
$2.05M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
aTYR PHARMA INC (ATYR) Q3 2020 Earnings Call Transcript
Revenue
$148,000
▼ 19.6% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
aTYR PHARMA INC (ATYR) Q2 2020 Earnings Call Transcript
Revenue
$189,000
▲ 101.1% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
aTYR PHARMA INC (ATYR) Q1 2020 Earnings Call Transcript
Revenue
$8.06M
Diluted EPS
$0.25
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-26
aTYR PHARMA INC (ATYR) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–20 of 20 webcasts
Key facts CIK 1339970 CUSIP 002120202 13F (30d) 1 filings 1 filers Visit website Investor relations